Among the top stories in hematology/oncology last week were a Q&A on the ability of phase 0 trials to accelerate the drug approval process for patients with glioblastoma and research that found modifiable cancer risk factors varied substantially along racial/ethnic and educational achievement lines.
No commercial support for this activity.
At Issue: Melanoma Resource Center
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.